Earnings Call · Q2 FY2026·2025-11-18

Q2 26EPS +3.82%·Rev n/aQ1 26EPS +2.44%·Rev n/aQ4 25EPS +2.53%·Rev n/aQ3 25EPS +2.21%·Rev n/a⚠ consensus missing

Medtronic plc MDT

Ryan Weispenning — Vice President and Head of Investor Relations

Geoffrey Martha — Chairman and Chief Executive Officer

Thierry Pieton — Chief Financial Officer

+4.7%1d on move date+5.5% vs SPY3d+3.2%5d+7.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDT calls or request research access.

More MDT calls Browse calls Request research access